| Endonita Hajzeraj, | |
|
1601 W Liberty St, Allentown, PA 18102-2071 | |
| (610) 820-9737 | |
| Not Available |
| Full Name | Endonita Hajzeraj |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1601 W Liberty St, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366217879 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP457275 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Endonita Hajzeraj, 1662 Jackson St, Whitehall, PA 18052-4174 Ph: () - | Endonita Hajzeraj, 1601 W Liberty St, Allentown, PA 18102-2071 Ph: (610) 820-9737 |
News Archive
Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumours in the chest region can be limited by the administration of an ACE inhibitor, a drug commonly used in the treatment of cardiovascular disease, a group of Dutch researchers have found.
Policymakers and economists often promote managed-care plans based on the assumption that they prevent the overuse of unnecessary surgical procedures or help steer patients to high-quality providers, compared to traditional fee-for-service insurance plans.
Researchers at Northwestern University Feinberg School of Medicine have developed the first animal model that duplicates the human response in rheumatoid arthritis (RA), an important step that may enable scientists to discover better medicines to treat the disease.
A small survey of military physicians found most did not receive any formal training on transgender care, most had not treated a patient with known gender dysphoria, and most had not received sufficient training to prescribe cross-hormone therapy, according to a new research letter published online by JAMA Internal Medicine.
A ground-breaking new class of oral drugs for treating breast cancer, known as cyclin-dependent kinase (CDK) inhibitors, are generally well-tolerated, with a manageable toxicity profile for most patients.
› Verified 9 days ago
Jacinta M Hudak, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1855 S 5th St, Allentown, PA 18103 Phone: 610-791-7796 | |
Mr. Michael Francis Mastroianni, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5829 Tilghman St, Allentown, PA 18104 Phone: 610-398-3228 Fax: 610-530-1815 | |
Bhavini Patel Miller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 361 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-821-7999 Fax: 610-821-8191 | |
Umesh Patel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1579 Kaitlyn Rd, Allentown, PA 18103 Phone: 484-221-9650 | |
Elizabeth Shober, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8887 | |
Mrs. Tammy Ann Hill, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6520 Stonegate Dr, Suite 100, Allentown, PA 18106 Phone: 610-794-5380 Fax: 610-794-5415 | |
Nicole Yeager, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 912 Airport Center Dr, Allentown, PA 18109 Phone: 610-573-5711 Fax: 610-573-5711 |